TranscutaneousO2(PtcO2)monitoring in Adults with ARDS

Jay Zhu,Charles Wo,W.C.Shoemaker
DOI: https://doi.org/10.3969/j.issn.1002-1949.2004.05.017
2004-01-01
Abstract:Objective The aim of clinical study is to evaluate the safety and efficacy of transcutaneousO 2 (PtcO 2),transcutaneous CO 2(PtcCO 2)in adult patients with the acute respiratory distress syndrome (ARDS)and to explore the new approach to treatment for ARDS.Method 93 patients (67 males,26 females,aged 44 35±18 23)with ARDS were observed in SICU of LAC+USC Health Care.All the patients were intubated and ventilated with CV (conventional ventilation).PaO 2,SaO 2,PaCO 2 were measured in CV model and in CV 0,8,16,24,48,72 Hrs respectively,and all the patients also had PtcO 2,PtcCO 2 continuous monitoring.Results Continuous PtcO 2 monitoring demonstrated significant improvement in PaO 2/FiO 2,PtcO 2/FiO 2 compared between survivor and non-survivor group.27 of 93 cases died, and mortality was 29 03% Conclusions PtcO 2 monitoring in ARDS is a safe and effective method on oxygenation resuscitation, and can significantly reduce mortality.
What problem does this paper attempt to address?